{"id":6986,"date":"2022-10-18T14:12:57","date_gmt":"2022-10-18T21:12:57","guid":{"rendered":"https:\/\/affderm.com\/?p=6986"},"modified":"2024-05-24T11:25:41","modified_gmt":"2024-05-24T18:25:41","slug":"inmunoterapia-postratamiento-en-melanoma","status":"publish","type":"post","link":"https:\/\/affderm.com\/es\/immunotherapy-post-treatment-in-melanoma\/","title":{"rendered":"Inmunoterapia postratamiento del melanoma"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Al ser la forma m\u00e1s grave de c\u00e1ncer de piel, el melanoma es un diagn\u00f3stico que nadie desea recibir. Sin embargo, si se detecta a tiempo, a menudo puede tratarse con \u00e9xito.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Existen varios tratamientos para el melanoma, y el plan de tratamiento de un paciente se basa principalmente en la gravedad y el estadio del melanoma o melanomas. Una opci\u00f3n es la inmunoterapia, un tratamiento farmacol\u00f3gico que ayuda al sistema inmunitario a combatir el c\u00e1ncer. Y ahora que los investigadores han descubierto que los beneficios de la inmunoterapia pueden durar m\u00e1s all\u00e1 del periodo de tratamiento, est\u00e1 demostrando ser un m\u00e9todo m\u00e1s prometedor de lo que se pensaba inicialmente.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Echemos un vistazo m\u00e1s de cerca a c\u00f3mo funciona la inmunoterapia para el melanoma y lo que hemos aprendido recientemente sobre los beneficios posteriores al tratamiento.<\/span><\/p>\n<p><img fetchpriority=\"high\" decoding=\"async\" class=\"alignnone size-medium wp-image-6988\" src=\"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_283557548-617x800.jpg\" alt=\"\u00bfQu\u00e9 es la inmunoterapia?\" width=\"617\" height=\"800\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">\u00bfQu\u00e9 es la inmunoterapia?<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">La inmunoterapia es un m\u00e9todo de tratamiento del c\u00e1ncer que se basa en f\u00e1rmacos especializados para dotar al sistema inmunitario de la capacidad de combatir las c\u00e9lulas cancerosas.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">A menudo, el sistema inmunitario del organismo no ataca de forma natural a las c\u00e9lulas cancerosas porque el c\u00e1ncer puede \"esconderse\" produciendo prote\u00ednas \u00fanicas. La inmunoterapia est\u00e1 dise\u00f1ada para interferir en ese proceso de producci\u00f3n, de modo que el sistema inmunitario pueda reconocer y combatir eficazmente las c\u00e9lulas cancerosas.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">Nuevos hallazgos: La inmunoterapia sigue funcionando tras el tratamiento del melanoma<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">A trav\u00e9s de <\/span><a href=\"https:\/\/www.dermatologytimes.com\/view\/long-term-benefits-of-pembrolizumab-in-melanoma\"><span style=\"font-weight: 400;\">un an\u00e1lisis de 10 a\u00f1os<\/span><\/a><span style=\"font-weight: 400;\"> de estudios de investigaci\u00f3n sobre el c\u00e1ncer, los cient\u00edficos descubrieron que el f\u00e1rmaco de inmunoterapia conocido como \"pembrolizumab\" mostraba beneficios a largo plazo que favorec\u00edan la supervivencia de los pacientes. Estos beneficios continuaron incluso despu\u00e9s de finalizar el tratamiento de inmunoterapia.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El an\u00e1lisis evalu\u00f3 los datos recogidos de m\u00e1s de 1.500 pacientes con melanoma avanzado que recibieron tratamiento con pembrolizumab. Los investigadores tambi\u00e9n examinaron informaci\u00f3n de otros estudios sobre nivolumab (otro f\u00e1rmaco de inmunoterapia) y datos comunicados por la Sociedad Americana contra el C\u00e1ncer.\u00a0<\/span><\/p>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">Sus resultados fueron muy prometedores:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Pembrolizumab aument\u00f3 tanto el <\/span><b>tasas de supervivencia global y sin progresi\u00f3n en pacientes con melanoma<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">El uso de pembrolizumab result\u00f3 muy beneficioso, <\/span><b>independientemente de la mutaci\u00f3n BRAF<\/b><span style=\"font-weight: 400;\"> (que se da en aproximadamente 40% de los casos de melanoma metast\u00e1sico) o los tratamientos anteriores de los pacientes con terapia dirigida a BRAF.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Uno de los <\/span><a href=\"http:\/\/pembrolizumab\"><span style=\"font-weight: 400;\">beneficios<\/span><\/a><span style=\"font-weight: 400;\"> de pembrolizumab fue su <\/span><b>actividad antitumoral<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Acerca <\/span><b>86% de los pacientes estaban libres de progresi\u00f3n<\/b><span style=\"font-weight: 400;\"> 20 meses despu\u00e9s de someterse durante dos a\u00f1os a un tratamiento de inmunoterapia contra el melanoma avanzado.<\/span><\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<p><span style=\"font-weight: 400;\">En esencia, la inmunoterapia ha abierto una nueva puerta a la mejora de los resultados del tratamiento del melanoma y, con m\u00e1s investigaci\u00f3n, los cient\u00edficos tienen la esperanza de poder avanzar a\u00fan m\u00e1s.<\/span><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">Educaci\u00f3n y prevenci\u00f3n del melanoma<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Por supuesto, la prevenci\u00f3n y la detecci\u00f3n precoz son las herramientas m\u00e1s eficaces para combatir el c\u00e1ncer de piel.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">He aqu\u00ed algunos datos fundamentales sobre la prevenci\u00f3n del melanoma:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los melanomas pueden aparecer en cualquier parte del cuerpo, no s\u00f3lo en las zonas expuestas al sol.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los primeros signos de melanoma son la aparici\u00f3n de un crecimiento inusual o pigmentado en la piel o cambios en un lunar existente.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Puede utilizar el m\u00e9todo \"ABCDE\" para evaluar lunares inusuales.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">Los melanomas ocultos (localizados en lugares inesperados como debajo de una u\u00f1a, en la boca o en el ojo) pueden suponer un riesgo especial para las personas con tonos de piel m\u00e1s oscuros.<\/span><\/li>\n<\/ul>\n<p><img decoding=\"async\" class=\"alignnone size-medium wp-image-6989\" src=\"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_671185342-800x533.jpg\" alt=\"Prevenir el melanoma ahora\" width=\"800\" height=\"533\" \/><\/p>\n<p>&nbsp;<\/p>\n<h2><span style=\"font-weight: 400;\">Obtenga ahora m\u00e1s informaci\u00f3n sobre c\u00f3mo prevenir el melanoma<\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Ahora es el momento si no se ha sometido a un cribado de c\u00e1ncer de piel en los \u00faltimos 12 meses. La detecci\u00f3n precoz es crucial para lograr resultados satisfactorios en el tratamiento y, a menudo, puede suponer literalmente la diferencia entre la vida y la muerte.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Affiliated Dermatology ofrece <\/span><a href=\"https:\/\/affderm.com\/es\/servicios\/tratamiento-del-cancer-de-piel-prevencion\/pruebas-de-deteccion-del-cancer-de-piel\/\"><span style=\"font-weight: 400;\">cribado del c\u00e1ncer de piel<\/span><\/a><span style=\"font-weight: 400;\"> y tratamiento en Phoenix, dando la bienvenida a los pacientes a <\/span><a href=\"https:\/\/affderm.com\/es\/lugares\/\"><span style=\"font-weight: 400;\">nuestras oficinas<\/span><\/a><span style=\"font-weight: 400;\"> en todo el Valle.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Programe su prueba de detecci\u00f3n de c\u00e1ncer de piel o solicite m\u00e1s informaci\u00f3n sobre las opciones de tratamiento cuando <\/span><a href=\"https:\/\/affderm.com\/es\/contacto\/\"><span style=\"font-weight: 400;\">p\u00f3ngase en contacto con nosotros<\/span><\/a><span style=\"font-weight: 400;\">.<\/span><\/p>","protected":false},"excerpt":{"rendered":"<p>As the most severe form of skin cancer, melanoma is a diagnosis that nobody wants to receive. However, if detected [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":6987,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[18],"tags":[],"class_list":["post-6986","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-dermatology"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Immunotherapy Post Treatment in Melanoma l Affiliated Dermatology<\/title>\n<meta name=\"description\" content=\"Researchers state Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma. Read more.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/affderm.com\/es\/inmunoterapia-postratamiento-en-melanoma\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Immunotherapy Post Treatment in Melanoma l Affiliated Dermatology\" \/>\n<meta property=\"og:description\" content=\"Researchers state Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma. Read more.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/affderm.com\/es\/inmunoterapia-postratamiento-en-melanoma\/\" \/>\n<meta property=\"og:site_name\" content=\"Affiliated Dermatology\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-18T21:12:57+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-24T18:25:41+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"2560\" \/>\n\t<meta property=\"og:image:height\" content=\"1638\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\\\/\\\/affderm.com\\\/#\\\/schema\\\/person\\\/19e9c838164803fbe858c9f8ee06a455\"},\"headline\":\"Immunotherapy Post Treatment in Melanoma\",\"datePublished\":\"2022-10-18T21:12:57+00:00\",\"dateModified\":\"2024-05-24T18:25:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/\"},\"wordCount\":552,\"image\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/affderm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/shutterstock_784036480-scaled.jpg\",\"articleSection\":[\"Medical Dermatology\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/\",\"url\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/\",\"name\":\"Immunotherapy Post Treatment in Melanoma l Affiliated Dermatology\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/affderm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/shutterstock_784036480-scaled.jpg\",\"datePublished\":\"2022-10-18T21:12:57+00:00\",\"dateModified\":\"2024-05-24T18:25:41+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/#\\\/schema\\\/person\\\/19e9c838164803fbe858c9f8ee06a455\"},\"description\":\"Researchers state Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma. Read more.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#primaryimage\",\"url\":\"https:\\\/\\\/affderm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/shutterstock_784036480-scaled.jpg\",\"contentUrl\":\"https:\\\/\\\/affderm.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/shutterstock_784036480-scaled.jpg\",\"width\":2560,\"height\":1638,\"caption\":\"Treating Melanoma\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/affderm.com\\\/immunotherapy-post-treatment-in-melanoma\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/affderm.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Immunotherapy Post Treatment in Melanoma\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/affderm.com\\\/#website\",\"url\":\"https:\\\/\\\/affderm.com\\\/\",\"name\":\"Affiliated Dermatology\",\"description\":\"Experts in Skin Disease Treatment &amp; Prevention\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/affderm.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/affderm.com\\\/#\\\/schema\\\/person\\\/19e9c838164803fbe858c9f8ee06a455\",\"name\":\"admin\",\"url\":\"https:\\\/\\\/affderm.com\\\/es\\\/author\\\/agency-it\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Inmunoterapia postratamiento en melanoma l Affiliated Dermatology","description":"Los investigadores afirman que el pembrolizumab tiene una actividad antitumoral duradera mucho despu\u00e9s de interrumpir el tratamiento en pacientes con melanoma avanzado. M\u00e1s informaci\u00f3n.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/affderm.com\/es\/inmunoterapia-postratamiento-en-melanoma\/","og_locale":"es_MX","og_type":"article","og_title":"Immunotherapy Post Treatment in Melanoma l Affiliated Dermatology","og_description":"Researchers state Pembrolizumab has antitumor activity that is durable long after treatment is stopped in patients with advanced melanoma. Read more.","og_url":"https:\/\/affderm.com\/es\/inmunoterapia-postratamiento-en-melanoma\/","og_site_name":"Affiliated Dermatology","article_published_time":"2022-10-18T21:12:57+00:00","article_modified_time":"2024-05-24T18:25:41+00:00","og_image":[{"width":2560,"height":1638,"url":"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"admin","Tiempo de lectura":"3 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#article","isPartOf":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/"},"author":{"name":"admin","@id":"https:\/\/affderm.com\/#\/schema\/person\/19e9c838164803fbe858c9f8ee06a455"},"headline":"Immunotherapy Post Treatment in Melanoma","datePublished":"2022-10-18T21:12:57+00:00","dateModified":"2024-05-24T18:25:41+00:00","mainEntityOfPage":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/"},"wordCount":552,"image":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#primaryimage"},"thumbnailUrl":"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg","articleSection":["Medical Dermatology"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/","url":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/","name":"Inmunoterapia postratamiento en melanoma l Affiliated Dermatology","isPartOf":{"@id":"https:\/\/affderm.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#primaryimage"},"image":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#primaryimage"},"thumbnailUrl":"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg","datePublished":"2022-10-18T21:12:57+00:00","dateModified":"2024-05-24T18:25:41+00:00","author":{"@id":"https:\/\/affderm.com\/#\/schema\/person\/19e9c838164803fbe858c9f8ee06a455"},"description":"Los investigadores afirman que el pembrolizumab tiene una actividad antitumoral duradera mucho despu\u00e9s de interrumpir el tratamiento en pacientes con melanoma avanzado. M\u00e1s informaci\u00f3n.","breadcrumb":{"@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#primaryimage","url":"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg","contentUrl":"https:\/\/affderm.com\/wp-content\/uploads\/2022\/10\/shutterstock_784036480-scaled.jpg","width":2560,"height":1638,"caption":"Treating Melanoma"},{"@type":"BreadcrumbList","@id":"https:\/\/affderm.com\/immunotherapy-post-treatment-in-melanoma\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/affderm.com\/"},{"@type":"ListItem","position":2,"name":"Immunotherapy Post Treatment in Melanoma"}]},{"@type":"WebSite","@id":"https:\/\/affderm.com\/#website","url":"https:\/\/affderm.com\/","name":"Dermatolog\u00eda afiliada","description":"Expertos en tratamiento y prevenci\u00f3n de enfermedades cut\u00e1neas","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/affderm.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/affderm.com\/#\/schema\/person\/19e9c838164803fbe858c9f8ee06a455","name":"admin","url":"https:\/\/affderm.com\/es\/author\/agency-it\/"}]}},"_links":{"self":[{"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/posts\/6986","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/comments?post=6986"}],"version-history":[{"count":0,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/posts\/6986\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/media\/6987"}],"wp:attachment":[{"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/media?parent=6986"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/categories?post=6986"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/affderm.com\/es\/wp-json\/wp\/v2\/tags?post=6986"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}